Acomplia or Rimonabant as Sanofi chose to brand it, was conceived as a one of a kind anti obesity drug that was meant to cure our society of a new found illness - being overweight. Sanofi R & D scientists were understandably proud of Acomplia; it was the first selective CB1 receptor blocker to be approved, to be used in conjunction with diet and exercise for patients with a BMI greater than 30 kg/m².
Acomplia was to accomplish what no modern day medicine had dared to. Rid the world of obesity. In fact, it was not a weight loss pill, as its inventors pointed out. It was a holistic medicine, which went into the reason why we gained weight, and addressed it with scientific precison. Acomplia suppressed appetite and worked systematically.
It wasn't a wonder drug, or wonder pill, it was a medicine which conceptually found favour with not only overweight patients but also their physicians, especially for patients with diabetes. If ever there was an ambitious dream that Sanofi had created for mankind and the medical world, Acomplia was it.
Acomplia was approved in the UK as a controlled medication and was under application in the US in 2006.
The active ingredient in Acomplia is rimonabant, which is a CB1 endocannabinoid receptor antagonist.
(The endocannabinoid system is in the part of the brain that regulates metabolism, energy levels and appetite).
However, in October 2008 concerns were raised over a small number of patients experiencing psychiatric symptoms possibly connected to the medication. As a result, it's now illegal to supply Acomplia in the U.K.
It is a medication that can prove invaluable for sufferers of obesity, as it can help them to get down to a healthier and safer weight more quickly, which means that they can reduce the risk of weight related health issues.
As anyone who has ever dieted will know, it can be extremely difficult to lose weight with diet and exercise alone. Of course, it can be done but without some help it can often take a long time to lose even small amounts of weight. Whilst many people who are trying to lose weight have the luxury of time on their side, there are many people who need to lose weight as quickly as possible for their own health.
Acomplia was to accomplish what no modern day medicine had dared to. Rid the world of obesity. In fact, it was not a weight loss pill, as its inventors pointed out. It was a holistic medicine, which went into the reason why we gained weight, and addressed it with scientific precison. Acomplia suppressed appetite and worked systematically.
It wasn't a wonder drug, or wonder pill, it was a medicine which conceptually found favour with not only overweight patients but also their physicians, especially for patients with diabetes. If ever there was an ambitious dream that Sanofi had created for mankind and the medical world, Acomplia was it.
Acomplia was approved in the UK as a controlled medication and was under application in the US in 2006.
The active ingredient in Acomplia is rimonabant, which is a CB1 endocannabinoid receptor antagonist.
(The endocannabinoid system is in the part of the brain that regulates metabolism, energy levels and appetite).
However, in October 2008 concerns were raised over a small number of patients experiencing psychiatric symptoms possibly connected to the medication. As a result, it's now illegal to supply Acomplia in the U.K.
It is a medication that can prove invaluable for sufferers of obesity, as it can help them to get down to a healthier and safer weight more quickly, which means that they can reduce the risk of weight related health issues.
As anyone who has ever dieted will know, it can be extremely difficult to lose weight with diet and exercise alone. Of course, it can be done but without some help it can often take a long time to lose even small amounts of weight. Whilst many people who are trying to lose weight have the luxury of time on their side, there are many people who need to lose weight as quickly as possible for their own health.
